Personalised type 2 diabetes therapy in primary care

Affiliations

¹ Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester LE5 4PW, UK; NIHR Applied Health Research Collaboration East Midlands and Leicester Real World Evidence Unit, Leicester Diabetes Centre, Leicester, UK. Electronic address: sis11@leicester.ac.uk.
² Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester LE5 4PW, UK; NIHR Applied Health Research Collaboration East Midlands and Leicester Real World Evidence Unit, Leicester Diabetes Centre, Leicester, UK.

Comment

Samuel Seidu et al. Lancet. 2025.

. 2025 Mar 1;405(10480):672-674.

doi: 10.1016/S0140-6736(24)02844-7. Epub 2025 Feb 25.

¹ Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester LE5 4PW, UK; NIHR Applied Health Research Collaboration East Midlands and Leicester Real World Evidence Unit, Leicester Diabetes Centre, Leicester, UK. Electronic address: sis11@leicester.ac.uk.
² Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester LE5 4PW, UK; NIHR Applied Health Research Collaboration East Midlands and Leicester Real World Evidence Unit, Leicester Diabetes Centre, Leicester, UK.

No abstract available

Comment on

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.
Dennis JM, Young KG, Cardoso P, Güdemann LM, McGovern AP, Farmer A, Holman RR, Sattar N, McKinley TJ, Pearson ER, Jones AG, Shields BM, Hattersley AT; MASTERMIND Consortium. Dennis JM, et al. Lancet. 2025 Mar 1;405(10480):701-714. doi: 10.1016/S0140-6736(24)02617-5. Epub 2025 Feb 25. Lancet. 2025. PMID: 40020703